Michael Robert Martin - Aug 9, 2021 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Signature
/s/ Michael Robert Martin
Stock symbol
AUPH
Transactions as of
Aug 9, 2021
Transactions value $
-$80,050
Form type
4
Date filed
8/10/2021, 04:09 PM
Previous filing
Jul 29, 2021
Next filing
Aug 27, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Sale -$80.1K -5K -2.36% $16.01 207K Aug 9, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2021.
F2 The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.00 to $16.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.